Atrial fibrillation and diabetes mellitus. Correlation, co-existence, and coagulation therapy

B Stratmann1, D Tschöpe

  • 1Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Georgstr. 11, 32545, Bad Oeynhausen, Deutschland.

Herz
|March 29, 2012
PubMed

Insights

Individuals with diabetes mellitus (DM) have a 40% higher risk of developing atrial fibrillation (AF). Poor glycemic control and longer diabetes duration increase this risk, necessitating screening and anticoagulation strategies.

Area of Science:

  • Cardiology
  • Endocrinology
  • Epidemiology

Background:

  • Diabetes mellitus (DM) and atrial fibrillation (AF) share common risk factors.
  • Existing epidemiological studies report inconsistent findings on the DM-AF association.
  • The underlying mechanisms linking DM and AF remain largely speculative.

Purpose of the Study:

  • To investigate the association between diabetes mellitus and the risk of subsequent atrial fibrillation.
  • To explore the impact of glycemic control and diabetes duration on AF risk.

Main Methods:

  • Review of epidemiological studies examining the relationship between DM and AF.
  • Analysis of risk factors common to both conditions.
  • Assessment of the influence of glycemic control and diabetes duration on AF incidence.

Main Results:

  • Individuals with DM exhibit an approximate 40% increased risk of developing AF compared to those without DM.
  • Higher risk of AF is associated with longer duration of treated diabetes.
  • Poorer glycemic control directly correlates with an elevated risk of AF.

Conclusions:

  • Diabetes mellitus is associated with a significantly increased risk of atrial fibrillation.
  • Glycemic control quality and diabetes duration are critical factors influencing AF risk in diabetic patients.
  • Future research should focus on screening and anticoagulation therapies to mitigate AF risk in individuals with DM.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...